Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2010
12/29/2010CN101468986B Method for splitting dihydropyrimidine racemic compound
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2766696A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/29/2010CA2766199A1 Thiazolylpiperidine derivates as fungicides
12/29/2010CA2766033A1 Prodrugs of nh-acidic compounds
12/29/2010CA2765983A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
12/29/2010CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/29/2010CA2765527A1 N-substituted-cyclic amino derivative
12/29/2010CA2764422A1 Insecticidal compounds
12/28/2010US7858803 Radiolabeled 2-(4'-methylamino)phenyl)-6-hydroxybenzothiazoles, and derivatives; diagnostic radioimaging of F-18 MHT exhibits abundant initial brain uptake; Differential accumulation indicates Alzheimer's disease or amyloidosis and can be monitored by positron emission tomography, SPECT camera
12/28/2010US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
12/28/2010US7858785 1-(2-{5-Chloro-4-[5-(4-fluoro-phenylimino)-4-methyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl]-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine, useful for treating diseases mediated by polo-like kinase 1, such as rheumatoid arthritis and breast cancer; antiproliferative agents
12/28/2010US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
12/28/2010US7858647 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative disorders ; N-{2-[4-(5-Isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-phenyl]-ethyl}-2-methoxy-4-trifluoromethyl-benzamide
12/28/2010US7858644 administering prostaglandin receptor antagonists such as N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide, used analgesics, neuroprtectants and diuretics, or for the treament of diabetes, tinitus, cancer, bone, blood, sleep, cardiovascular and sexual disorders
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858632 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/23/2010WO2010148121A2 Benzothiazole derivatives
12/23/2010WO2010147792A2 Compounds which selectively modulate the cb2 receptor
12/23/2010WO2010147791A1 Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
12/23/2010WO2010147430A2 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same
12/23/2010WO2010146605A1 Novel gpr 119 agonists
12/23/2010WO2010146338A1 Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
12/23/2010WO2010146105A1 S1p1 agonists comprising a bicyclic n-containing ring
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145202A1 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
12/23/2010WO2010145201A1 Compounds
12/23/2010WO2010145186A1 Peptide deformylase inhibitor containing 2,5-dihydropyrrole and synthesis method thereof
12/23/2010WO2010128528A3 Piperidine derivatives useful for treatment of diebetes
12/23/2010WO2010126626A3 Dual mechanism inhibitors for the treatment of disease
12/23/2010US20100324290 Crystalline form i of lamivudine and its preparation
12/23/2010US20100324286 Benzothiazole derivatives
12/23/2010US20100324284 Pyrrolopyrimidine derivative as p13k inhibitor and use thereof
12/23/2010US20100324105 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
12/23/2010US20100324096 Whitening Agent And Skin External Preparation
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324032 Compounds and uses thereof in modulating amyloid beta
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324024 Quinolizidinone M1 Receptor Positive Allosteric Modulators
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324014 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324013 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324012 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324011 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324010 Amide compounds and use of the same
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010CA2765822A1 Novel gpr 119 agonists
12/23/2010CA2765525A1 Compounds which selectively modulate the cb2 receptor
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2262802A1 Pim kinase inhibitors and methods of their use
12/22/2010EP2262801A1 Heterocyclic urea derivatives and methods of use thereof-211
12/22/2010EP2262800A1 Novel pyrimidine-pyridine derivatives
12/22/2010EP2262798A2 Substituted enaminothiocarbonyl compounds
12/22/2010EP2262794A1 Sulfonamide compounds and their use as fungicide
12/22/2010CN1902186B Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN101925598A Fungicidal amides
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925590A Aldh-2 inhibitors in treatment of addiction
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101925573A Novel N-(2-amino-phenyl)-amide derivatives
12/22/2010CN101921269A Method for preparing HCV (Hepatitis C Virus) inhibitor
12/22/2010CN101921268A 5-thiazole amide compound and biology application thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921256A Diphenyl pyrone amide derivative and preparation method and application thereof
12/22/2010CN101921224A 1-(3-aminopropyl) piperazine-4-aminoamide compound as well as preparation method and application thereof
12/22/2010CN101386620B Thiazole derivative and preparation method and application thereof
12/22/2010CN101260107B Diheterocycle compound containing 4-thiazolidinone and pyrimidine, synthetic method and application thereof
12/22/2010CN101128436B Glycine derivative and use thereof
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855210 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2659682C Prolyl hydroxylase inhibitors and methods of use
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/16/2010WO2010144647A1 Nicotinamide compounds useful as kinase modulators
12/16/2010WO2010144513A1 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010WO2010143158A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010WO2010143116A1 Fluorinated aminotriazole derivatives
12/16/2010WO2010142978A1 Heterocyclic urea derivatives and methods of use thereof
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 628